Results 161 to 170 of about 13,009 (197)
Some of the next articles are maybe not open access.
Monocarboxylate transporter MCT1 is a target for immunosuppression
Nature Chemical Biology, 2005Current immunosuppressive therapies act on T lymphocytes by modulation of cytokine production, modulation of signaling pathways or by inhibition of the enzymes of nucleotide biosynthesis. We have identified a previously unknown series of immunomodulatory compounds that potently inhibit human and rat T lymphocyte proliferation in vitro and in vivo in ...
Clare M, Murray +26 more
openaire +2 more sources
The neuroimaging findings of monocarboxylate transporter 1 deficiency
Neuroradiology, 2020Monocarboxylate transporter 1 (MCT1) deficiency was first described in 2014 by Hasselt et al. as a novel genetic cause of recurrent ketoacidosis. Patients present in the first year of life with acute episodes of ketoacidosis triggered by fasting or infections.
Manal Nicolas-Jilwan +3 more
openaire +2 more sources
Metabolism, 2002
Diabetes is known to alter both oxidative and glycolytic pathways in a fiber type-dependent manner. In various skeletal muscles of normal rats, monocarboxylate transporter 1 (MCT1) has been found to be highly correlated to lactate uptake, as well as to oxidative capacity, whereas the distribution and characteristics of MCT4 make it a good candidate for
Guillaume, Py +5 more
openaire +2 more sources
Diabetes is known to alter both oxidative and glycolytic pathways in a fiber type-dependent manner. In various skeletal muscles of normal rats, monocarboxylate transporter 1 (MCT1) has been found to be highly correlated to lactate uptake, as well as to oxidative capacity, whereas the distribution and characteristics of MCT4 make it a good candidate for
Guillaume, Py +5 more
openaire +2 more sources
Monocarboxylate Transporters are not Responsible for Cr3+ Transport from Endosomes
Biological Trace Element Research, 2012Cr(3+), similar to Fe(3+), is transported into cells primarily via endocytosis as the metal-transferrin complex. As Cr(3+) ions are not readily reduced under biological conditions, the ion cannot be transported from endosomes by the same mechanism as iron that utilized divalent metal ion transporters.
Nicholas R, Rhodes +3 more
openaire +2 more sources
Functional characteristics of the cardiac sarcolemmal monocarboxylate transporter
The Journal of Membrane Biology, 1989We have previously shown that a mechanism for transporting L-lactate is located in cardiac sarcolemmal membranes (Am. J. Physiol. 252:C483-C489, 1987). This mechanism has now been shown to transport pyruvate also. The transporter recognizes a wide range of monocarboxylic acids with chain lengths of three to six carbons, as evidenced by their ability to
T L, Trosper, K D, Philipson
openaire +2 more sources
Inhibition of monocarboxylate transporter by N-cyanosulphonamide S0859
European Journal of Pharmacology, 2015The synthetic compound N-cyanosulphonamide S0859 has been described as a selective inhibitor of sodium-bicarbonate cotransporters (NBC, SLC4) in mammalian heart (Ch'en et al., 2008). First, for comparison, the electrogenic human NBCe1 (SLC4A4) was heterologously expressed in Xenopus laevis oocytes, where its transport activity was inhibited by S0859 ...
Hella, Heidtmann +3 more
openaire +2 more sources
Expression of monocarboxylate transporters in rat ocular tissues
American Journal of Physiology-Cell Physiology, 2005The aim of the present study was to determine the distribution of monocarboxylate transporter (MCT) subtypes 1-4 in the various structures of the rat eye by using a combination of conventional and real-time RT-PCR, immunoblotting, and immunohistochemistry. Retinal samples expressed mRNAs encoding all four MCTs.
Glyn, Chidlow +3 more
openaire +2 more sources
Transport of Hexoses and Monocarboxylic Acids
1983Although the dependence of the mammalian brain, under normal conditions, on a regular supply of glucose from the bloodstream has been acknowledged for 50 years or more, ways by which glucose passes to the brain and how it travels within the brain were ignored until relatively recently.
openaire +1 more source
Structural basis of human monocarboxylate transporter 1 inhibition by anti-cancer drug candidates
Cell, 2021Nan Wang, Chuangye Yan, Shuo Zhang
exaly

